Form 4: Surgery Partners Executive Sells Shares to Cover Tax Obligations

Harrison R. Bane, American Group President at Surgery Partners, sold shares of common stock on March 4, 2024, to cover tax withholding obligations related to vesting restricted stock.

Summary

• On March 4, 2024, Harrison R. Bane, American Group President of Surgery Partners, Inc., sold 1,800 shares of common stock at a weighted average price of $30.53.
• He also sold 3,304 shares of common stock at a weighted average price of $30.53.
• These transactions were to satisfy tax withholding obligations related to the vesting of restricted stock on March 2, 2024.
• Following these transactions, Bane directly owns 53,310 shares of Surgery Partners, Inc.
• The sales were executed under Transaction Code 'S', indicating a sale.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction (selling shares to cover taxes) and doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor potential shifts in sentiment or alignment of interests.

Comparison to Industry Standards

• Form 4 filings are a standard regulatory requirement for publicly traded companies, ensuring transparency in insider trading activities.
• Similar filings are common across the healthcare industry, with executives at companies like HCA Healthcare and Tenet Healthcare regularly reporting transactions in their company's stock.

Stakeholder Impact

• The sale of shares by an executive could be perceived neutrally by shareholders as it is related to tax obligations.
• The impact on other stakeholders (employees, customers, suppliers, creditors) is likely minimal.

Key Dates